CONMED Corporation
CNMD
$44.50
$1.082.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.61% | 3.94% | 4.32% | 5.00% | 10.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.61% | 3.94% | 4.32% | 5.00% | 10.23% |
| Cost of Revenue | 3.08% | 1.80% | 2.36% | 2.61% | 6.70% |
| Gross Profit | 5.81% | 5.63% | 5.88% | 6.94% | 13.18% |
| SG&A Expenses | 7.20% | 5.79% | 4.68% | 2.59% | 6.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.70% | 3.49% | 3.31% | 2.64% | 6.68% |
| Operating Income | 3.91% | 7.40% | 12.57% | 25.55% | 47.79% |
| Income Before Tax | -46.58% | 11.13% | 39.96% | 101.70% | 440.63% |
| Income Tax Expenses | -24.34% | 8.65% | 23.66% | 86.96% | 199.88% |
| Earnings from Continuing Operations | -51.37% | 11.77% | 44.20% | 105.44% | 127.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.37% | 11.77% | 44.20% | 105.44% | 127.25% |
| EBIT | 3.91% | 7.40% | 12.57% | 25.55% | 47.79% |
| EBITDA | 3.52% | 5.63% | 8.50% | 16.66% | 28.69% |
| EPS Basic | -51.56% | 11.32% | 43.61% | 104.60% | 125.66% |
| Normalized Basic EPS | 9.19% | 13.30% | 20.23% | 39.14% | 82.41% |
| EPS Diluted | -51.31% | 12.39% | 45.55% | 107.80% | 126.86% |
| Normalized Diluted EPS | 10.23% | 14.88% | 22.47% | 41.80% | 85.16% |
| Average Basic Shares Outstanding | 0.48% | 0.49% | 0.51% | 0.57% | 0.66% |
| Average Diluted Shares Outstanding | -0.47% | -0.88% | -1.38% | -1.23% | -0.50% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.07% | -0.10% | -0.30% | -0.51% | -0.56% |